Clinical Trial Update: Role of Hyperpolarized 13C-Pyruvate MR Spectroscopy in Patients With Intracranial Metastasis Treated With (SRS) [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating hyperpolarized 13C-pyruvate MR spectroscopy as an imaging biomarker in patients with brain metastases treated by stereotactic ra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Brain Metastases | Phase 1 | Status: RECRUITING